Merck
-
{
- All
- News
- Videos
- Web Stories
-
Bundibugyo Strain Of Ebola Virus Explained: The Rare Strain Responsible For The Current Outbreak
Tests for Bundibugyo exist but are not widely used. Initial analysis of samples in the current outbreak using standard tests did not detect the infections.
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
New Oral Pill Enlicitide Cuts 'Bad' Cholesterol By 60% In Landmark Trial
The new oral pill enlicitide cuts bad cholesterol risk by 60% in a new landmark trial. Here are the mechanisms behind it and why the oral pill could revolutionise cholesterol management.
-
Chinese Cat Owners Are Feeding Covid-19 Pills To Their Pets. Here's Why
Merck & Co.'s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as antidotes to a life-threatening disease caused by a coronavirus that infects their feline companions.
-
US Health Advisers Back Pfizer, Merck Pneumonia Shots For Adults Over 50
A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc and Merck & Co that protect against pneumococcal disease, clearing a path for wider use.
-
Pfizer, Merck Pneumonia Shots Approved For Adults Over 50
A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and Merck & Co. that protect against pneumococcal disease, clearing a path for wider use.
-
Germany's Tech Company Merck To Open Semiconductor Base in China
Germany's Merck KGaA said on Tuesday it had signed a contract to open a semiconductor base in the Chinese city of Zhangjiagang.
-
WHO Gives Nod To Merck Covid Pill For Non-Severe, At-Risk Patients
The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.
-
Anti-Covid Pill "Active" Against Omicron: Merck
Merck's anti-Covid pill remains "active" against the Omicron variant, the US drugmaker said Friday, citing results from six laboratory studies.
-
105 Nations To Get Cheaper Merck Covid Pill
Generic drug manufacturers will make a more affordable version of Merck's anti-Covid pill for 105 of the world's poorer nations, a UN-backed organisation said on Thursday.
-
Merck's Covid Pill Not In India's Treatment Plan, Has Major Safety Concerns
India has not added Merck's pill to the list of treatments for Covid due to 'major safety concerns', a top health official said today.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
The Covid Pill For India: What We Know
Dr. D Srinivasa Reddy, CMD, Optimus Pharma Private Limited, spoke to NDTV today to explain the basics of the recently-cleared Covid pill for India. Molnupiravir has been licensed by US pharma giant Merck for over a dozen Indian firms.
-
India Clears 2 New Vaccines And Merck's Covid Pill: 10 Points
The centre cleared two more vaccines today and one anti-viral drug to boost the fight against the COVID-19 pandemic. The two latest vaccines cleared by India are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.
-
Now, 2 Covid Pills For At-Home Treatment As Omicron Spreads
Merck & Co.'s Covid-19 pill was cleared by US regulators Thursday, giving high-risk patients a second at-home treatment just as the Omicron variant is causing cases to surge around the country.
-
Bundibugyo Strain Of Ebola Virus Explained: The Rare Strain Responsible For The Current Outbreak
Tests for Bundibugyo exist but are not widely used. Initial analysis of samples in the current outbreak using standard tests did not detect the infections.
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
New Oral Pill Enlicitide Cuts 'Bad' Cholesterol By 60% In Landmark Trial
The new oral pill enlicitide cuts bad cholesterol risk by 60% in a new landmark trial. Here are the mechanisms behind it and why the oral pill could revolutionise cholesterol management.
-
Chinese Cat Owners Are Feeding Covid-19 Pills To Their Pets. Here's Why
Merck & Co.'s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as antidotes to a life-threatening disease caused by a coronavirus that infects their feline companions.
-
US Health Advisers Back Pfizer, Merck Pneumonia Shots For Adults Over 50
A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc and Merck & Co that protect against pneumococcal disease, clearing a path for wider use.
-
Pfizer, Merck Pneumonia Shots Approved For Adults Over 50
A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and Merck & Co. that protect against pneumococcal disease, clearing a path for wider use.
-
Germany's Tech Company Merck To Open Semiconductor Base in China
Germany's Merck KGaA said on Tuesday it had signed a contract to open a semiconductor base in the Chinese city of Zhangjiagang.
-
WHO Gives Nod To Merck Covid Pill For Non-Severe, At-Risk Patients
The World Health Organization on Wednesday recommended an anti-Covid pill be taken by sufferers who have mild symptoms but are at high risk of hospitalisation, such as older people or the unvaccinated.
-
Anti-Covid Pill "Active" Against Omicron: Merck
Merck's anti-Covid pill remains "active" against the Omicron variant, the US drugmaker said Friday, citing results from six laboratory studies.
-
105 Nations To Get Cheaper Merck Covid Pill
Generic drug manufacturers will make a more affordable version of Merck's anti-Covid pill for 105 of the world's poorer nations, a UN-backed organisation said on Thursday.
-
Merck's Covid Pill Not In India's Treatment Plan, Has Major Safety Concerns
India has not added Merck's pill to the list of treatments for Covid due to 'major safety concerns', a top health official said today.
-
Merck's Anti- Covid Pill 'Molflu' 5-Day Course To Cost Rs 1,400 In India
Drugmaker Dr Reddy's Laboratories Ltd will launch its generic version of Merck's antiviral COVID-19 pill, molnupiravir.
-
The Covid Pill For India: What We Know
Dr. D Srinivasa Reddy, CMD, Optimus Pharma Private Limited, spoke to NDTV today to explain the basics of the recently-cleared Covid pill for India. Molnupiravir has been licensed by US pharma giant Merck for over a dozen Indian firms.
-
India Clears 2 New Vaccines And Merck's Covid Pill: 10 Points
The centre cleared two more vaccines today and one anti-viral drug to boost the fight against the COVID-19 pandemic. The two latest vaccines cleared by India are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.
-
Now, 2 Covid Pills For At-Home Treatment As Omicron Spreads
Merck & Co.'s Covid-19 pill was cleared by US regulators Thursday, giving high-risk patients a second at-home treatment just as the Omicron variant is causing cases to surge around the country.
